MCID: CYT003
MIFTS: 10

Cytokine Receptor Deficiency malady

Categories: Rare diseases

Aliases & Classifications for Cytokine Receptor Deficiency

Aliases & Descriptions for Cytokine Receptor Deficiency:

Name: Cytokine Receptor Deficiency 50

Classifications:



Summaries for Cytokine Receptor Deficiency

MalaCards based summary : Cytokine Receptor Deficiency The drugs Tenofovir and Emtricitabine have been mentioned in the context of this disorder.

Wikipedia : 71 Cytokine receptors are receptors that bind... more...

Related Diseases for Cytokine Receptor Deficiency

Symptoms & Phenotypes for Cytokine Receptor Deficiency

Drugs & Therapeutics for Cytokine Receptor Deficiency

Drugs for Cytokine Receptor Deficiency (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 87)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Tenofovir Approved, Investigational Phase 4 147127-20-6 464205
2
Emtricitabine Approved, Investigational Phase 4 143491-57-0 60877
3 Nucleic Acid Synthesis Inhibitors Phase 4,Phase 2
4 Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination Phase 4
5 Anti-HIV Agents Phase 4,Phase 2
6 Anti-Infective Agents Phase 4,Phase 2
7 Anti-Retroviral Agents Phase 4,Phase 2
8 Reverse Transcriptase Inhibitors Phase 4,Phase 2
9 Antiviral Agents Phase 4,Phase 2
10
Testosterone Approved, Investigational Phase 3 58-22-0 6013
11
Methyltestosterone Approved Phase 3 58-18-4 6010
12
Cholecalciferol Approved, Nutraceutical Phase 3,Phase 2,Early Phase 1 67-97-0 6221 10883523 5280795
13
Ergocalciferol Approved, Nutraceutical Phase 3,Phase 2,Early Phase 1 50-14-6 5280793
14 vitamin d Phase 3,Phase 2,Early Phase 1
15 insulin Phase 3,Phase 2
16 Trace Elements Phase 3,Phase 2,Early Phase 1
17 Hormone Antagonists Phase 3,Phase 2
18 Hormones Phase 3,Phase 2
19 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 3,Phase 2
20 Ergocalciferols Phase 3,Phase 2,Early Phase 1
21 Vitamins Phase 3,Phase 2,Early Phase 1
22 Insulin, Globin Zinc Phase 3,Phase 2
23 Micronutrients Phase 3,Phase 2,Early Phase 1
24 Bone Density Conservation Agents Phase 3,Phase 2,Early Phase 1
25 Testosterone undecanoate Phase 3
26 Testosterone 17 beta-cypionate Phase 3
27
Testosterone enanthate Phase 3 315-37-7 9416
28 Androgens Phase 3
29 Interleukin 1 Receptor Antagonist Protein Phase 3
30 Antirheumatic Agents Phase 3
31 Vitamin D2 Nutraceutical Phase 3,Phase 2,Early Phase 1
32 Calciferol Nutraceutical Phase 3,Phase 2,Early Phase 1
33
Mannitol Approved, Investigational Phase 2 69-65-8 453 6251
34
Ritonavir Approved, Investigational Phase 2 155213-67-5 392622
35
Nevirapine Approved Phase 2 129618-40-2 4463
36
Alendronate Approved Phase 2 121268-17-5, 66376-36-1 2088
37
Stavudine Approved, Investigational Phase 2 3056-17-5 18283
38
Zoledronic acid Approved Phase 2 118072-93-8 68740
39
Calcium carbonate Approved Phase 2 471-34-1
40
Daclizumab Approved, Investigational Phase 1, Phase 2 152923-56-3
41
Triamcinolone Approved, Vet_approved Phase 1, Phase 2 124-94-7 31307
42
Riluzole Approved, Investigational Phase 2 1744-22-5 5070
43 triamcinolone acetonide Phase 1, Phase 2
44 Interleukin-2 Phase 1, Phase 2
45 Analgesics Phase 1, Phase 2
46
protease inhibitors Phase 2
47 Cinacalcet Hydrochloride Phase 2
48 Gastrointestinal Agents Phase 2,Phase 1
49 HIV Protease Inhibitors Phase 2
50 Cytochrome P-450 CYP3A Inducers Phase 2

Interventional clinical trials:

(show all 28)
id Name Status NCT ID Phase
1 PrEP, Lube, and the Rectal Mucosa in MSM at Risk of HIV Completed NCT02401230 Phase 4
2 Hypovitaminosis D : A Link Between Bone/Mineral and Fat/Fuel Metabolism Completed NCT01315366 Phase 3
3 Study of the Efficacy and Safety of Cholecalciferol Supplementation on the Activity of Rheumatoid Arthritis in Patients With Vitamin D Deficiency Recruiting NCT02243800 Phase 3
4 Effects of Interleukin-1 Beta on Low Testosterone Levels in Men With Obesity and Metabolic Syndrome Recruiting NCT02672592 Phase 3
5 Bone Loss and Immune Reconstitution in HIV/AIDS (BLIR-HIV) Completed NCT01228318 Phase 2
6 Vitamin D, Insulin Resistance and Inflammation in ESRD Completed NCT00656032 Phase 2
7 Supplementation With Cholecalciferol in Dialysis Patients Completed NCT01974245 Phase 2
8 Ilaris (Canakinumab) in the Schnitzler Syndrome Completed NCT01245127 Phase 2
9 Anti-Tac for Treatment of Leukemia Completed NCT00001941 Phase 1, Phase 2
10 Pharmacodynamics of Intermittent IL-2 Infusions in HIV Seropositive Patients Completed NCT00001474 Phase 2
11 Immune Response to Toll-Like Receptor 9-Agonist Adjuvanted Pneumococcal Vaccination in HIV Infected Adults Completed NCT00562939 Phase 1, Phase 2
12 A Pilot Study of the Immunologic Reconstitution in HIV-1 Infected Children Receiving Highly Active Antiretroviral Therapy With Combination Ritonavir, Nevirapine and Stavudine Completed NCT00001688 Phase 2
13 Safety and Effectiveness of Alendronate for Bone Mineral Density in HIV-infected Children and Adolescents Completed NCT00921557 Phase 2
14 A Trial of Tocilizumab in ALS Subjects Recruiting NCT02469896 Phase 2
15 Pilot-Study of Thalidomide in Amyotrophic Lateral Sclerosis (ALS) Terminated NCT00231140 Phase 2
16 Safety and Immunogenicity Study of Na-GST-1 With or Without CpG Completed NCT02143518 Phase 1
17 Evaluating the Immune Response to a rAd5 HIV Vaccine Administered in Three Different Ways in Healthy, HIV-Uninfected Adults Active, not recruiting NCT01479296 Phase 1
18 Reactivation of CMV Infection in Immunocompetent Patients Under Severe Stress Unknown status NCT01397058
19 Efferocytosis and Genomic Polymorphism in Autoimmune Diseases Unknown status NCT00364728
20 Effect of HIV Infection and Highly Active Antiretroviral Treatment (HAART) on Bone Homeostasis Completed NCT01020045
21 Study of the Pathobiology of Bronchopulmonary Dysplasia in Newborns Completed NCT00006058
22 Interferon Responses in Eczema Herpeticum Completed NCT01429311
23 The Effects of Illnesses on HIV Levels in the Body Completed NCT00000900
24 Idiopathic CD4 Lymphocytopenia Recruiting NCT02113930
25 Genetic Basis of Primary Immunodeficiencies Recruiting NCT00001788
26 Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases (NOMID / CAPS, DIRA, CANDLE, SAVI, CRMO, Still's Disease, Behcet's Disease, and Other Undifferentiated Autoinflammatory Diseases) Recruiting NCT00059748
27 Detection of Annexin A2 in Systemic Lupus Erythematosus Not yet recruiting NCT03031925
28 Effects of Vitamin D on Renin Expression in Hypertensive Patients Terminated NCT00585442 Early Phase 1

Search NIH Clinical Center for Cytokine Receptor Deficiency

Genetic Tests for Cytokine Receptor Deficiency

Anatomical Context for Cytokine Receptor Deficiency

Publications for Cytokine Receptor Deficiency

Articles related to Cytokine Receptor Deficiency:

id Title Authors Year
1
Nitric oxide production in experimental gram-negative infection: studies with cytokine receptor-deficient mice. ( 9688089 )
1998

Variations for Cytokine Receptor Deficiency

Expression for Cytokine Receptor Deficiency

Search GEO for disease gene expression data for Cytokine Receptor Deficiency.

Pathways for Cytokine Receptor Deficiency

GO Terms for Cytokine Receptor Deficiency

Sources for Cytokine Receptor Deficiency

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....